NO983098D0 - Hudheftende farmas°ytisk preparat, spesielt transdermalt terapeutisk system for frigivelse av 17-<beta>-estradiol til den menneskelige organisme - Google Patents

Hudheftende farmas°ytisk preparat, spesielt transdermalt terapeutisk system for frigivelse av 17-<beta>-estradiol til den menneskelige organisme

Info

Publication number
NO983098D0
NO983098D0 NO983098A NO983098A NO983098D0 NO 983098 D0 NO983098 D0 NO 983098D0 NO 983098 A NO983098 A NO 983098A NO 983098 A NO983098 A NO 983098A NO 983098 D0 NO983098 D0 NO 983098D0
Authority
NO
Norway
Prior art keywords
estradiol
beta
release
pharmaceutical preparation
air humidity
Prior art date
Application number
NO983098A
Other languages
English (en)
Other versions
NO312878B1 (no
NO983098L (no
Inventor
Bodo Asmussen
Michael Horstmann
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO983098D0 publication Critical patent/NO983098D0/no
Publication of NO983098L publication Critical patent/NO983098L/no
Publication of NO312878B1 publication Critical patent/NO312878B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NO19983098A 1996-01-08 1998-07-03 Hudheftende farmasöytisk preparat, fremgangsmåte for fremstilling av samme, samt anvendelse av slike preparater NO312878B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19600347A DE19600347A1 (de) 1996-01-08 1996-01-08 Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
PCT/EP1996/005822 WO1997025077A1 (de) 1996-01-08 1996-12-23 HAUTHAFTENDE PHARMAZEUTISCHE ZUBEREITUNG, INSBESONDERE TTS ZUR ABGABE VON 17-β-ESTRADIOL AN DEN MENSCHLICHEN ORGANISMUS

Publications (3)

Publication Number Publication Date
NO983098D0 true NO983098D0 (no) 1998-07-03
NO983098L NO983098L (no) 1998-07-03
NO312878B1 NO312878B1 (no) 2002-07-15

Family

ID=7782261

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983098A NO312878B1 (no) 1996-01-08 1998-07-03 Hudheftende farmasöytisk preparat, fremgangsmåte for fremstilling av samme, samt anvendelse av slike preparater

Country Status (21)

Country Link
US (1) US6267982B1 (no)
EP (1) EP0880366B1 (no)
JP (1) JP2000505071A (no)
KR (1) KR100476579B1 (no)
CN (1) CN1107525C (no)
AT (1) ATE205406T1 (no)
AU (1) AU721677B2 (no)
CA (1) CA2242577C (no)
CZ (1) CZ289291B6 (no)
DE (2) DE19600347A1 (no)
DK (1) DK0880366T3 (no)
ES (1) ES2164270T3 (no)
HU (1) HUP9901102A3 (no)
IL (1) IL125160A (no)
MY (1) MY129733A (no)
NO (1) NO312878B1 (no)
NZ (1) NZ325817A (no)
PL (1) PL187275B1 (no)
SK (1) SK282984B6 (no)
WO (1) WO1997025077A1 (no)
ZA (1) ZA97111B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6623763B2 (en) * 1996-01-08 2003-09-23 Lts Lohmann Therape-System Ag Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism
US20020039597A1 (en) * 1998-04-20 2002-04-04 Koji Ukai Stabilized compositions containing benzimidazole-type compounds
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
WO2001064937A2 (en) * 2000-03-02 2001-09-07 Mcgill University Caspase-inhibitory-factor (cif) and uses thereof
US20070158227A1 (en) * 2004-01-30 2007-07-12 Satoshi Amano Plaster enclosing packaging bag

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
AU633887B2 (en) * 1989-02-28 1993-02-11 Teijin Limited Poultice and preparation thereof
IT1253265B (it) * 1991-11-25 1995-07-14 Rotta Research Lab Preparato a matrice copolimerica adesiva a base acrilica per il rilascio transdermico dell'estradiolo.
DE4223360C1 (no) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4237453C1 (no) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE4429664C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
NO312878B1 (no) 2002-07-15
DE59607696D1 (de) 2001-10-18
HUP9901102A2 (hu) 1999-08-30
WO1997025077A1 (de) 1997-07-17
CA2242577C (en) 2006-06-06
CZ289291B6 (cs) 2001-12-12
EP0880366B1 (de) 2001-09-12
MY129733A (en) 2007-04-30
NZ325817A (en) 1999-01-28
HUP9901102A3 (en) 1999-11-29
CN1107525C (zh) 2003-05-07
CA2242577A1 (en) 1997-07-17
NO983098L (no) 1998-07-03
DK0880366T3 (da) 2001-12-27
IL125160A0 (en) 1999-01-26
DE19600347A1 (de) 1997-07-10
CN1207049A (zh) 1999-02-03
KR19990077110A (ko) 1999-10-25
AU1305797A (en) 1997-08-01
AU721677B2 (en) 2000-07-13
KR100476579B1 (ko) 2005-09-26
PL187275B1 (pl) 2004-06-30
SK282984B6 (sk) 2003-01-09
US6267982B1 (en) 2001-07-31
IL125160A (en) 2003-01-12
ATE205406T1 (de) 2001-09-15
ZA97111B (en) 1997-08-18
PL327940A1 (en) 1999-01-04
JP2000505071A (ja) 2000-04-25
ES2164270T3 (es) 2002-02-16
CZ214098A3 (cs) 1998-11-11
SK90898A3 (en) 1999-01-11
EP0880366A1 (de) 1998-12-02

Similar Documents

Publication Publication Date Title
RU2176499C2 (ru) Композиция для чрескожного введения стероидных лекарственных средств и содержащий ее препарат
KR880012216A (ko) 활성성분 배합물용 경피성 치료계
KR900005969A (ko) 게스토덴을 함유하는 경피 투여용 제제
CA2320132A1 (en) Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
NZ228826A (en) Transdermal adhesive medicament containing eucalyptol (1,8 cineol)
ZA946698B (en) Medical device for the administration of active ingredients or drugs at very low doses particularly homeopathic drugs
FI952115A0 (fi) Trandermaalinen terapeuttinen menetelmä 17-beta-estradiolin antamiseen ja menetelmä järjestelmän valmistamiseksi
NO951523D0 (no) Plaster for transdermal administrering av flyktige, farmasöytisk aktive, kjemisk basiske bestanddeler, samt fremgangsmåte for fremstilling av plasteret
KR100281235B1 (ko) 활성성분으로서 17-β-에스트라디올 무수물을 함유하는 경피치료계
SE8401113L (sv) Forfarande for framstellning av pa huden fixerbara, krampstillande produkter, i synnerhet muskelkrampstillande
NO983098D0 (no) Hudheftende farmas°ytisk preparat, spesielt transdermalt terapeutisk system for frigivelse av 17-&lt;beta&gt;-estradiol til den menneskelige organisme
Aqil et al. Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil
KR970705381A (ko) 흡수성 첨가제를 함유하는 에스트라디올 트랜스더멀 치료 시스템
US20030235543A1 (en) Topical administration of pharmacologically active bases for skin lightening
KR20000029523A (ko) 치매치료및(또는)예방용제제
WO2004000259A1 (en) Topical administration of pharmacologically active bases for skin lightening
KR100272043B1 (ko) 알쯔하이머성 치매치료용 경피흡수제제
RU2001102050A (ru) Лекарственная форма
AU2003235046A1 (en) Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
MX9804617A (es) Preparacion farmaceutica estabilizada en la superficie para aplicarse sobre la piel.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees